February 9, 2023
  • Abbott Laboratories has agreed to acquire Cardiovascular Systems Inc. (CSI) in a deal with a total equity value of about $890 million. In a statement, Abbott officials said the deal would strengthen its portfolio of devices treating vascular disease. The companies have agreed to the terms, but the transaction still needs approval from CSI stockholders and regulators. (Article here)